Mar 26 2015

Cord Blood Bank Shows Surge in Quarterly Growth Ahead of Inc. 5000 Announcement

Posted by admin

The First Quarter 2015 Sets the Stage for yet Another Strong Year

New York – March 26, 2015 – Americord Registry, a private cord blood banking company, announced today that it has seen a sharp spike in quarterly growth during the first months of 2015, showing a strong start for the year after recently applying for the Inc. 5000.

“This growth reinforces our position as one of the fastest growing cord blood banks in the industry,” said Americord CEO Martin Smithmyer. “We applied for the Inc. 5000 due to our considerable growth in past years, and we are looking to maintain this trajectory into the future.”

Americord is predicting a 50 percent quarterly growth at the close of March, setting the stage for increased revenue this year and into the next. The Inc. 5000 contains the 5,000 fastest growing private companies in America, and securing a spot can be difficult. In 2013, companies that made the Inc. 5000 had to demonstrate a 942 percent growth rate over a three-year period.

“We’ve worked hard to qualify for the Inc. 5000 this year,” said Smithmyer. “And we’re proud to say that we’re building on that growth for the coming year.”

About Americord Registry

Americord Registry is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in all 50 states. The company’s laboratory is CLIA Certified, accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Americord is headquartered in New York, NY. You may visit Americord Registry’s website at for more information.

< Back to Blog
Category: Press